Surgical Ablation During CABG Linked to Improved Survival in Patients with Atrial Fibrillation

A recent study published in The Annals of Thoracic Surgery has shed light on the benefits of performing surgical ablation during coronary artery bypass grafting (CABG) in patients with preexisting atrial fibrillation (AF). The research analyzed Medicare data from over 87,000 patients who underwent CABG between 2008 and 2019. Despite strong clinical guidelines recommending concomitant ablation, it was only performed in about 22% of cases, with rates increasing modestly to 27% by 2019, two years after a Class I recommendation was issued.

The findings revealed that patients who received surgical ablation experienced a median survival improvement of approximately 4.4 months compared to those who did not undergo ablation (7.82 versus 7.46 years; P<0.001). Notably, patients treated by surgeons with higher ablation frequencies had even better outcomes, with a median survival advantage of nearly five months. The benefits of ablation appeared late, manifesting over two years post-procedure, likely due to a reduction in tachycardia-related heart failure.

To ensure the results were not biased by patient health status, researchers employed advanced statistical methods, including overlap propensity score weighting and surgeon-preference instrumental variable analysis. These approaches helped simulate randomization, strengthening the evidence that surgical ablation can positively impact survival.

Given that 10-20% of patients undergoing CABG have AF—linked to perioperative complications and reduced long-term survival—these findings emphasize the importance of adherence to guidelines that recommend ablation. Surgeons and clinicians are encouraged to reconsider current practices, as the data suggest that more widespread implementation of surgical ablation could significantly improve long-term outcomes for patients with AF undergoing CABG.

Source: Medical Xpress